Different effects of oxidative stress on activation of transcription factors in primary cultured rat neuronal and glial cells

Molecular Brain Research

Volumn 50, Issue 1-2, 1997, Pages 213-220

  Iwata, Emi ^a   Asanuma, Masato ^a   Nishibayashi, Sakiko ^a   Kondo, Yoichi ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Brain derived neurotrophic factor; Cell viability; Culture; DNA binding activity; Glia; Neuron; Oxidative stress; Transcription factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HYDROGEN PEROXIDE; OXIDOPAMINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; GEL MOBILITY SHIFT ASSAY; GLIA CELL; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HYDROGEN PEROXIDE; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; OLIGONUCLEOTIDE PROBES; OXIDATIVE STRESS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0030661960     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00190-3     Document Type: Article

References (45)

1. J.D. Adams, I.N. Odunze, Oxygen free radicals and Parkinson's disease, Free Radic. Biol. Med. 10 (1991) 161-169.
2. I.M. Adcock, C.R. Brown, O. Kwon, P.J. Barnes, Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells, Biochem. Biophys. Res. Commun. 199 (1994) 1518-1524.
3. R.F. Alderson, A.L. Alterman, Y.-A Barde, R.M. Lindsay, Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture, Neuron 5 (1990) 297-306.
4. C.A. Altar, C.B. Boylan, M. Fritsche, B.E. Jones, C Jackson, S.J. Wiegand, R.M. Lindsay, C. Hyman, Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions, J. Neurochem. 63 (1994) 1021-1032.
5. L.M. Ambani, M.H. Van Woert, S. Murphy, Brain peroxidase and catalase in Parkinson's disease, Arch Neurol. 32 (1975) 114-118.
6. M. Asanuma, S Nishibayashi, Y. Kondo, E. Iwata, M. Tsuda, N. Ogawa, Effects of single cyclosporin A pretreatment on pentylenetetrazol-induced convulsion and on TRE-binding activity in the rat brain, Mol. Brain Res. 33 (1995) 29-36.
7. A.N. Basma, E.J. Morris, W.J. Nicklas, H.M. Geller, L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation, J. Neurochem. 64 (1995) 825-832.
8. C. Bromont, C. Marie, J. Bralet, Increased lipid peroxidation in vulnerable brain regions after transient cortex ischemia in rats, Stroke 20 (1989) 918-924.
9. J.N. Chacon, M.R. Chedekel, E.J. Land, T.G. Truscott, Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenylpyridinium ion, Biochem. Biophys. Res. Commun. 144 (1987) 957-964.
10. G. Cohen, Monoamine oxidase, hydrogen peroxide, and Parkinson's disease, Adv. Neurol. 45 (1986) 119-125.
11. G. Cohen, R. Heikkila, The generation of hydrogen peroxide superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytoioxic agents, J. Biol. Chem. 249 (1974) 2447-2452.
12. S.T. DeKosky, J.R. Goss, P.D. Miller, S.D. Styren, P.M. Kochanek, D. Marion, Upregulation of nerve growth factor following cortical trauma, Exp. Neurol. 130 (1994) 173-177.
13. Y. Devary, R.A. Gottlieb, L.F. Lau, M. Karin, Rapid and preferential activation of the c-jun gene during the mammalian UV response, Mol. Cell. Biol. 11 (1991) 2804-2811.
14. D.T. Dexter, F.R. Wells, A.J. Lees, Y. Agid, P. Jenner, C.D. Marsden, Increase nigral iron content and alterations in other metal ions occurring in brain in Parkmson's disease, J. Neurochem. 52 (1989) 1830-1836.
15. M.T. Fernández-Sánchez, A. Novelli, Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity, FEBS Lett. 335 (1993) 124-131.
16. 2 by iron salts, Proc. R. Soc. Lond. A 147 ( 1934) 332-351.
17. B. Halliwell, Reactive oxygen species and the central nervous system, J. Neurochem. 59 (1992) 1609-1623.
18. B. Halliwell, J.M.C. Gutteridge, Oxygen radicals and nervous system, Trends Neurosci. 8 (1985) 22-26.
19. R. Heikkila, G. Cohen, Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine, Mol. Pharmacol. 8 (1972) 241-248.
20. R.E. Heikkila, G. Cohen, 6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate, Science 181 (1973) 157-456.
21. C. Hyman, M. Hofer, Y.-A. Barde, M. Juhasz, G. Yancopoulos, S.P. Squinto, R.M. Lindsay, BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra, Nature 350 (1991) 230-232.
22. Y. Iwamoto, T. Yamaki, N. Murakami, N. Sugawa, E. Yoshino, S. Ueda, K. Nosaka, H. Nishino. A. Iwashima, Basic fibroblast growth factor messenger RNA is expressed strongly at the acute stage of cerebral contusion, Life Sci. 55 (1994) 1651-1656.
23. E. Iwata, T. Nakanishi, N. Ogawa, K. Ohyama, T Murakami, M. Takigawa, Neurotrophin-3 increase the DNA-binding activities of several transcription factors in a mouse osteoblastic cell line, Biochem. Biophys. Acta 1311 (1996) 85-92.
24. D.B. Jacoby, A.M. Choi, Influenza virus induces expression of antioxidant genes in human epithelial cells, Free Radic. Biol. Med 16 (1994) 821-824.
25. G.R. Jackson, D. Sampath, K. Werrbach-Perez, J.R. Perez-Polo, Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone, Brain Res. 634 (1994) 69-76.
26. S.J. Kish, C. Morito, O. Hornykiewicz, Glutathione peroxidase activity in Parkinson's disease, Neurosci. Lett. 58 (1985) 343-346.
27. B. Knüsel, J.W. Winslow, A. Rosenthal, L.E. Burton, D.P. Seid, K. Nikolics, F. Hefti, Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3, Proc. Natl. Acad. Sci. USA 88 (1991) 961-965.
28. J.-Y. Koh, B.J. Gwag, D. Lobner, D.W. Choi, Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 268 (1995) 573-575.
29. H.A. Kontos, Oxygen radicals in CNS damage, Chem. Biol. Interact. 72 (1989) 229-255.
30. R.M. Lindsay. H. Thoenen, Y.-A. Barde, Placode and neural crest-derived sensory neurons are responsive at early developmental states to brain-derived neurotrophic factor (BDNF). Dev. Biol. 112 (1985) 319-328.
31. T.K. Makar, M. Nedergaard, A. Preuss, A.S. Gelbard, A.S. Perumal, A.J.L. Cooper, Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain, J. Neurochem. 62 (1994) 45-53.
32. 2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor, EMBO J. 12 (1993) 2005-2015.
33. M. Mizuno, L. Packer, Effects of alpha-lipoic acid and dihydrohpoic acid on expression of proto-oncogene c-fos, Biochem. Biophys. Res. Commun. 200 (1994) 1136-1142.
34. G. Nistico, M.R. Ciriolo, K. Fiskin, M. Iannone, A. De Martino, G. Rotilio, NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats, Free Radic. Biol. Med. 12 (1992) 177-181.
35. K. Nose, M. Shibanuma, K. Kikuchi, H. Kageyama, S. Sakiyama, T. Kuroki, Transcription activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line, Eur. J. Biochem. 201 (1991) 99-106.
36. N. Ogawa, Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages, Eur. Neurol. 34 (Suppl. 3) (1994) 20-28.
37. B. Pardo, M.A. Mena, M.J. Casarejos, C.L. Paíno, J.G. De Yébe nes, Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants, Brain Res. 682 (1995) 133-143.
38. C.K. Petito, S. Morgello, J.C. Felix, ML. Lesser, The two patterns of reactive astrocytosis in postischemic rat brain, J. Cereb. Blood Flow Metab. 10 (1990) 850-859.
39. P. Riederer, E. Sofic, W.D. Rausche, B. Schmidt, G.P. Reynolds, K. Jallinger, M.B.H. Youdim, Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains, J. Neurochem. 52 (1989) 515-520.
40. Z.A. Ronai, M.E. Lambert, I.B. Weinstein, Inducible cellular responses to ultraviolet light irradiation and other mediators of DNA damage in mammalian cells, Cell Biol. Toxicol. 6 (1990) 105-126.
41. D.R. Rosen, T. Siddique, D Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J.P. O'Regan, H.-X. Deng, Z. Rahmani, A. Krizus, D. McKenna-Yasek, A. Cayabyab, S.M. Gaston, R. Berger, R.E. Tanzi, J.J. Halperin, B. Herzfeldt, R. Van den Bergh, W.-Y. Hung, T. Bird, G. Deng, D.W. Mulder, C. Smyth, N.G. Laing, E. Soriano, M.A. Pericak-Vance, J. Haines, G.A. Rouleau, J.S. Gusella, H.R, Horvitz, R.H.J. Brown, Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature 362 (1993) 59-62.
42. E. Schreiber, P. Matthias, M.M Müler, W. Schaffner, Rapid detection of octamer binding proteins with 'mini-extracts'. preparation from a small number of cells, Nucleic Acids Res. 17 (1989) 6419.
43. B.K. Siesjo, Cerebral circulation and metabolism, J Neurosurg, 60 (1984) 883-908.
44. M.B. Spina, S.P. Squinto, J. Miller, R.M. Lindsay, C. Hyman, Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system, J. Neurochem. 59 (1992) 99-106.
45. M.J. Zigmond, T.W. Berger, A.A. Grace, E.M. Stricker, Compensatory responses to nigrostriatal bundle injury: studies with 6-hydroxydopamine in an animal model of parkinsonism, Mol. Chem. Neuropathol. 10 (1989) 185-200.